Segall Bryant & Hamill LLC Purchases Shares of 262,207 Ardent Health Partners, LLC (NYSE:ARDT)

Segall Bryant & Hamill LLC purchased a new position in Ardent Health Partners, LLC (NYSE:ARDT) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 262,207 shares of the company’s stock, valued at approximately $4,478,000.

A number of other large investors have also recently made changes to their positions in the stock. Wellington Management Group LLP purchased a new stake in Ardent Health Partners in the 3rd quarter worth approximately $28,724,000. Point72 Asset Management L.P. bought a new position in shares of Ardent Health Partners in the third quarter worth approximately $27,428,000. Goldentree Asset Management LP bought a new position in shares of Ardent Health Partners in the third quarter worth approximately $22,897,000. Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners in the third quarter worth $15,839,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Ardent Health Partners by 9.2% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 779,601 shares of the company’s stock valued at $13,136,000 after purchasing an additional 65,833 shares during the period.

Ardent Health Partners Price Performance

Ardent Health Partners stock opened at $13.15 on Friday. The company’s 50-day moving average price is $14.43 and its 200-day moving average price is $16.28. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners, LLC has a twelve month low of $12.87 and a twelve month high of $20.72.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ARDT. Stephens reiterated an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a research note on Wednesday. Morgan Stanley cut their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Truist Financial dropped their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada dropped their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $21.18.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.